EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial

Jonathan I Silverberg, Lawrence F Eichenfield, April W Armstrong, Jerry Bagel, Ben Lockshin, Erin Boh, John Koo, Aaron S Farberg, Matthew S Goldberg, Ann P Quick, Mark G Lebwohl

Journal of the American Academy of Dermatology · 2026

DOI: 10.1016/j.jaad.2026.02.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Jonathan I Silverberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Gene Expression Profiling, Janus Kinase Inhibitors, Psoriasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Castle Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicGene Expression ProfilingJanus Kinase InhibitorsPsoriasisTranscriptomeHumansFemaleProspective StudiesMaleAdultSeverity of Illness IndexTreatment OutcomeMiddle AgedPyrimidinesAlgorithmsYoung Adult

Stichwörter der Autor:innen

487-gene expression profileJAK inhibitorJAKi Responder ProfileTh2 Molecular ProfileTh2-targeted therapyatopic dermatitisinflammationsystemic therapy

Substanzen

Janus Kinase InhibitorsPyrimidines

Autor:innen und Institutionen

  • Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
  • Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California.
  • Division of Dermatology, University of California Los Angeles, Los Angeles, California.
  • Director Eczema Center of New Jersey, Clinical Professor of Dermatology at The Icahn School of Medicine at Mount Sinai, East Windsor, New Jersey.
  • US Dermatology Partners, Rockville, Maryland.
  • Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana.

Förderung

  • Castle Biosciences

Zitieren

APA

Silverberg, J. I., Eichenfield, L. F., Armstrong, A. W., Bagel, J., Lockshin, B., Boh, E., Koo, J., Farberg, A. S., Goldberg, M. S., Quick, A. P., & Lebwohl, M. G. (2026). The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.02.034

Vancouver

Silverberg JI, Eichenfield LF, Armstrong AW, Bagel J, Lockshin B, Boh E, et al. The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.02.034

BibTeX
@article{Silverberg2026,
  author = {Silverberg, Jonathan I and Eichenfield, Lawrence F and Armstrong, April W and Bagel, Jerry and Lockshin, Ben and Boh, Erin and Koo, John and Farberg, Aaron S and Goldberg, Matthew S and Quick, Ann P and Lebwohl, Mark G},
  title = {The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.02.034}
}
Kostenlos starten →